纤维蛋白原摄取试验在髋部骨折患者深静脉血栓筛查中的应用。
The use of fibrinogen uptake test in screening for deep vein thrombosis in patients with hip fracture.
作者信息
Faunø P, Suomalainen O, Bergqvist D, Fredin H, Kettunen K, Soimakallio S, Cederholm C, Karjalainen P, Vissinger H, Justesen T
机构信息
Department of Orthopedic Surgery, Arhus, Denmark.
出版信息
Thromb Res. 1990 Nov 1;60(3):185-90. doi: 10.1016/0049-3848(90)90179-g.
255 hip fracture patients were studied by 125I-fibrinogen uptake test and bilateral phlebography. We found the sensitivity of fibrinogen scanning to be 44% for the non-operated limb and 50% for the calves. The predictive value of a negative result was found to be 92% and 93% respectively. We conclude that the use of fibrinogen uptake test as single diagnosticum is not valid and can only be recommended in combination with phlebography when studying patient where the frequency of DVT is expected to be low.
对255例髋部骨折患者进行了125I-纤维蛋白原摄取试验和双侧静脉造影研究。我们发现，纤维蛋白原扫描对未手术侧肢体的敏感性为44%，对小腿的敏感性为50%。阴性结果的预测值分别为92%和93%。我们得出结论，将纤维蛋白原摄取试验作为单一诊断方法是无效的，仅在研究深静脉血栓形成（DVT）发生率预计较低的患者时，建议与静脉造影联合使用。
Zotero 插件